New FDA Drug Approved to Help Premenopausal Women with Hypoactive Sexual Desire Disorder.

New FDA Drug Approved to Help Premenopausal Women with Hypoactive Sexual Desire Disorder.

Vyleesi was recently approved by the FDA for premenopausal women who have low libido.   

 

How is it given?

Given subcutaneously 45 minutes before intercourse

 

What are the results?

Women exhibit marked increase in sexual desire and consequently a very satisfying sexual interaction.

 

Who benefits from this treatment?

 

It benefits premenopausal women with

Hypoactive Sexual Desire Disorder(HSDD)

 

Who does not benefit from Vyeelesi Treatment?

  1. Postmenopausal Women
  2. Men
  3. For anyone trying to enhance sexual performance

 

Any side effects?

   1. Transient increase in blood pressure

  1. Transient lowering of heart rate
  2. Nausea and or vomiting
  3. Focal hyperpigmentation
  4. Flushing
  5. Injection site reaction
  6. Headache                            

  

Contraindications:

  1. Uncontrolled hypertension
  2. Pregnancy

 

Vyeelesi can help young women who do not have any medical or psychological issues affecting their sexual life including relationship issues or due to taking medications or drugs.

 

If you want to learn more or need help please call us at 703 992 9815 or send us an email @ info@zinniaaesthetics.com

Author
Dr. Anteneh Roba

You Might Also Enjoy...